Library/Viral infections/Influenza

Viral infections evidence library

Influenza

A living PubMed evidence library for human influenza prevention, antiviral treatment, vaccines, severe disease, resistance, and emerging strains.

PubMed only Research ranked Conflicts shown Data downloadable

Living evidence synopsis

What the current PubMed collection shows.

Alexandria currently organizes 0 non-retracted PubMed-indexed records for Influenza. The structured collection includes 0 guideline or consensus records, 0 evidence syntheses/systematic reviews/meta-analyses, and 0 randomized or phase III studies. 0 records were identified by the configured last-24-month search. Conflict-of-interest statements are available in the PubMed record for 0 of 0 included records.

Engine 0.3.2 Snapshot v9 Updated 2026-09-27 Download source data · CSV
PubMed records0Non-retracted records included
Last 24 months0Records found by the recent-research search
High-priority evidence0Syntheses, reviews, randomized and phase III studies
Effect estimates0Machine-readable values extracted from abstracts
COI statements0%Coverage within PubMed records
Funding records0PMIDs with grant/funding metadata
Evidence data

Research landscape

Charts are generated from Alexandria’s structured PubMed records, not copied from journal figures.

Publication activity

Records by publication year

Latest 12 represented years
Evidence composition

Study designs

Transparency

Conflict-of-interest reporting

Absence of a conflict-of-interest statement in PubMed does not establish that no conflict existed.

Abstract result signals

Extracted result direction

Research transparency

Funding and conflicts of interest

Conflict and funding fields reproduce what is available in PubMed records. Missing disclosure data does not establish that no conflict or funding existed.

COI statement coverage0%0 records have no COI statement exposed in PubMed.
Funding metadata coverage0%Coverage indicates whether grant/funding metadata was present, not independence or study quality.
Most frequently reported funding agencies

No funding agency was identified in the retrieved PubMed records.

01

Current Standard-of-Care Sources

Alexandria uses this label only for PubMed-indexed guidelines or consensus documents. These are source publications, not individualized recommendations.

No eligible guideline has been indexed in this snapshot.

The absence of a result is shown rather than filled from outside knowledge.

02

Highest-Priority Research

High-priority evidence has not been processed yet.

03

Latest Research — Last 24 Months

No recent records have been processed yet.

04

Treatment Options Studied in the PubMed Collection

These are interventions detected in PubMed metadata and abstracts. Inclusion does not establish approval, effectiveness, suitability, or standard-of-care status.

Structured treatment extraction has not completed yet.

The background evidence pipeline will populate this section after PubMed retrieval and extraction.

05

Conflicting Research

No directly conflicting cluster has been identified yet.

This can mean the evidence is consistent, insufficient, or not detailed enough in the available abstracts to compare.

06

Failed or Negative Trials

No trial with a directly extractable failed/null primary finding has been processed yet.

07

Emerging and Experimental Research

No early-phase or preclinical record has been processed yet.

08

Evidence Gaps

No randomized or phase III evidence identified

The current PubMed collection does not contain a classified randomized or phase III study for this topic.

No PubMed-indexed guideline identified

Alexandria did not identify a guideline or consensus publication in the configured searches.

R

Complete Ranked PubMed Index

The retrieval-priority score orders records using publication type, recency, sample-size signals, and replication signals. It is not a recommendation or a formal risk-of-bias grade.

Current Standard Of Care10 records
Rank110.0
Clinical guideline or consensus statement

Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Policy Statement.

Pediatrics · 2024 · PMID 39183669

This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2024-2025 influenza season. A detailed review of the evidence supporting these recommendations is published in the accompanying technical report (www.pediatrics.org/cgi/doi/10.1542/peds.2024-068508). The American Academy of Pediatrics recommends annual influenza vaccination of all children without medi…

Rank110.0
Clinical guideline or consensus statement

Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report.

Pediatrics · 2024 · PMID 39183667

This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2024 to 2025 season. The rationale for the American Academy of Pediatrics recommendation for annual influenza vaccination of all children without medical contraindications starting at 6 months of age is provided. Influenza vaccination is an important strategy for protecting children and the b…

Rank103.0
Systematic review or meta-analysis

Improving vaccination uptake among adolescents.

The Cochrane database of systematic reviews · 2020 · PMID 31978259

BACKGROUND: Adolescent vaccination has received increased attention since the Global Vaccine Action Plan's call to extend the benefits of immunisation more equitably beyond childhood. In recent years, many programmes have been launched to increase the uptake of different vaccines in adolescent populations; however, vaccination coverage among adolescents remains suboptimal. Therefore, understanding and evaluating the various interventions that can be used to improve adolescent vaccination is crucial. OBJECTIVES: To …

Rank101.0
Systematic review or meta-analysis

Healthcare system disruption across WHO-declared PHEICs: a 4S comparative case analysis.

Frontiers in public health · 2026 · PMID 42807059

OBJECTIVES: To compare documented patterns of healthcare-system disruption and response across WHO-declared Public Health Emergencies of International Concern (PHEICs) using the established 4S surge-capacity framework (Staff, Stuff, Space, Systems) and an author-developed 12-indicator operationalization. METHODS: We conducted a structured comparative case analysis, not a systematic review of intervention effects, of all eight PHEIC events declared by WHO through 31 March 2026. The unit of analysis was the event, an…

Rank92.4
Randomized clinical study

Postural Orthostatic Tachycardia Syndrome (POTS): A Review.

JAMA · 2026 · PMID 42635998

IMPORTANCE: Postural orthostatic tachycardia syndrome (POTS) is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. POTS can substantially impair daily functioning and quality of life. OBSERVATIONS: Consensus criteria define POTS by chronic symptoms of orthostatic intolerance accompanied by a sustained heart rate increase of at least 30 beats/min (≥40 beats/min in adolescents aged 12-19 years) within 10 m…

Rank85.0
Randomized clinical study

[Influenza vaccination as an intervention for cardiovascular prevention and protection in high-risk patients. SIPREC/ANMCO/SIMI/FADOI/ARCA consensus document].

Giornale italiano di cardiologia (2006) · 2026 · PMID 42788302

Influenza infection is associated with an increase of cardiovascular events and hospitalizations due to cardiovascular disease. Influenza vaccination is in turn associated with a reduction or mitigation of cardiovascular complications of influenza. For this reason, influenza vaccination represents an additional pillar for cardiovascular prevention and protection. Recent randomized studies conducted in a very large European population have shown that high-dose influenza vaccination provides significant advantages wh…

Rank60.0
Observational or cohort study

What do those who vaccinate think? Perception of the flu among pediatrician and pediatric nursing professionals.

Anales de pediatria · 2026 · PMID 42668227

INTRODUCTION: Childhood influenza represents a significant healthcare burden, in terms of both primary care and hospital emergency department visits, as well as in hospitalizations. The objective of this study was to analyze the perceptions of pediatricians and nurses working in pediatric settings regarding childhood influenza and influenza vaccination, as well as the perceived barriers, in order to identify new strategies to improve vaccination coverage. MATERIALS AND METHODS: Cross-sectional, observational, and d…

Rank47.0
Other PubMed-indexed publication

Consensus based expert recommendations for management and prevention of RSV infections in older adults in emerging market countries: results from an expert panel structured survey.

Expert review of vaccines · 2026 · PMID 42596759

BACKGROUND: Respiratory syncytial virus (RSV) can cause serious disease in older adults (OAs), particularly those with comorbidities. It is a leading cause of acute respiratory illness and lower respiratory tract infections in adults ≥60 years. Its impact on morbidity, mortality, and healthcare systems is becoming evident. Questions about the burden of disease (BoD) are raised due to underdiagnosis and the similarity with other respiratory illnesses. First opportunities for prevention came in 2023 and 2024, with va…

Rank45.0
Other PubMed-indexed publication

[Comprehensive cardiovascular prevention: the role of vaccination in older adults with cardiovascular disease. Expert consensus document].

Semergen · 2026 · PMID 42508371

INTRODUCTION: Respiratory and systemic infections can trigger cardiovascular events by increasing inflammation, atherosclerotic plaque instability, and a prothrombotic state. Given this situation, vaccination is a relevant preventive tool in patients with cardiovascular disease (CVD). OBJECTIVE: To review the available evidence on the impact of vaccination in patients with CVD and to propose recommendations to improve vaccination coverage in clinical practice. CONTENT: This expert consensus, developed through a str…

Rank45.0
Other PubMed-indexed publication

Guided design for the development of an evolution-proof influenza vaccine.

Vaccine · 2025 · PMID 40398325

Influenza remains a significant public health concern, particularly among high-risk populations, due to its capacity to cause annual epidemics and potentially trigger global pandemics. Despite the availability of countermeasures such as vaccines and antiviral treatments, their effectiveness is hindered by factors such as resistance development with manufacturing of the influenza vaccine still heavily relying on decades-old technologies. This review therefore examines the mechanisms by which influenza viruses evade …

i
Research information notice

Alexandria organizes PubMed-indexed literature. PubMed inclusion does not establish accuracy, endorsement, clinical applicability, or treatment suitability. Automated extraction can contain errors or omissions. This page is not medical advice.